Article: Drug decision brings hope of relief to eczema sufferers

A DRUG to treat patients with severe eczema on their hands was approved for use in Scotland yesterday.

An estimated 12,000 people in Scotland suffer from chronic eczema on their hands.

Yesterday, the Scottish Medicines Consortium approved the use of Toctino (alitretinoin), a one-a-day capsule, for use in patients whose condition fails to improve with powerful steroid creams.

The drug is the first to be developed specifically for chronic hand eczema.

Dr Roger Aldridge, a consultant dermatologist at the Royal Infirmary of Edinburgh, said: "Chronic hand eczema can be severely disabling for patients and difficult ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!